Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Master Style PCLBKK:MASTER 56 EV-to-EBITDA is 7.12 as of Jul. 27, 2026, which is 63% below its 10-year median of 19.50. GuruFocus rates BKK:MASTER with a GF Score™ of 56/100 and a GF Value™ of ฿41.61 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Master Style PCL ranks better than 71.32% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Master Style PCL's enterprise value is ฿3,116 Mil.
Master Style PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿438 Mil. Therefore, Master Style PCL's EV-to-EBITDA for today is 7.12.
The historical rank and industry rank for Master Style PCL's EV-to-EBITDA or its related term are showing as below:
BKK:MASTER'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.52 Med: 19.5 Max: 60.44
Current: 7.12
During the past 6 years, the highest EV-to-EBITDA of Master Style PCL was 60.44. The lowest was 4.52. And the median was 19.50.
BKK:MASTER's EV-to-EBITDA is ranked better than 71.32% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 10.97
vs BKK:MASTER: 7.12
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Master Style PCL's PE Ratio (TTM) for today is calculated as:
Master Style PCL's share price for today is ฿8.80.
Master Style PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.663.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Master Style PCL's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:MASTER vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Master Style PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Master Style PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Master Style PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Master Style PCL's EV-to-EBITDA falls into.
Master Style PCL's current Enterprise Value is ฿3,116 Mil.
Master Style PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿438 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Master Style PCL (BKK:MASTER) has a EV-to-EBITDA of 7.12 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Master Style PCL. This is 63% below median its historical median of 19.50. Over the past decade, Master Style PCL's EV-to-EBITDA has ranged from 4.52 to 60.44. According to the industry distribution chart, Master Style PCL ranks #146 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 28.7%.
Is Master Style PCL's EV-to-EBITDA too high?
Master Style PCL's current EV-to-EBITDA of 7.12 is 63% below median its 10-year median of 19.50. Over the past 10 years, this metric has ranged from a low of 4.52 to a high of 60.44. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.97. Master Style PCL's value of 7.12 is 35.1% below this industry median. Based on the distribution chart, Master Style PCL ranks #146 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Master Style PCL has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Master Style PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Master Style PCL ranks #146 out of 509 companies for EV-to-EBITDA. This puts Master Style PCL in the upper half of its industry. The industry median EV-to-EBITDA is 10.97. Master Style PCL's value of 7.12 is 35.1% below this benchmark. Historically, Master Style PCL's own EV-to-EBITDA has ranged from 4.52 to 60.44 over the past decade. While the company's 10-year median is 19.50 vs. the industry median of 10.97, Master Style PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.97, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Master Style PCL's current EV-to-EBITDA of 7.12 is 35.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Master Style PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Master Style PCL's current EV-to-EBITDA is 7.12, which is 63% below median its own 10-year median of 19.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Master Style PCL stock overvalued right now?
Based on GuruFocus' analysis, Master Style PCL (BKK:MASTER) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿41.61, compared to a current price of ฿8.80 — trading 78.9% below its estimated fair value. The current EV-to-EBITDA is 7.12, which is 63% below median its 10-year median of 19.50 and 35.1% below the Healthcare Providers & Services industry median of 10.97. Master Style PCL's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Master Style PCL (BKK:MASTER), the current EV-to-EBITDA is 7.12 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Master Style PCL (BKK:MASTER) Overvalued in 2026?
Based on GuruFocus' analysis, Master Style PCL stock appears to be undervalued.
The current stock price of ฿8.80 is trading 78.9% below its estimated GF Value™ of ฿41.61.
GuruFocus considers Master Style PCL to be Significantly Undervalued.
Key valuation signals for BKK:MASTER:
EV-to-EBITDA: 7.12 (63% below median its 10-year median of 19.50)
GF Value™: ฿41.61 vs. price of ฿8.80 (78.9% below fair value)
Industry Position: 35.1% below the Healthcare Providers & Services median (#146 of 509)
No single metric tells the full story. See the BKK:MASTER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Master Style PCL is principally engaged in a cosmetic surgery hospital under the name of Masterpiece Hospital. It is a skincare and cosmetic surgery clinic. The company's services include: eye surgery, Nose surgery, Facial surgery, Hair transplant Liposuction and others. The company has two principal segments; Hospital business, which generates the majority of the revenue, and the trading of cosmetic products.
56GF Score
Get the complete analysis for BKK:MASTER
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MASTER has been successfully added to your 
